Overview

Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Status:
Terminated

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The objective is to evaluate whether ONO-2952 modulates visceral pain perception produced by rectal distention in female patients with IBS-D

Phase:

Phase 2

Details

Lead Sponsor:

Ono Pharma USA Inc